Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years)

NCT00973700 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

784

Enrollment

INDUSTRY

Sponsor class

Conditions

Novel 2009 Influenza H1N1

Interventions

BIOLOGICAL: MF59-eH1N1_f
BIOLOGICAL: eH1N1_f

Sponsor

Novartis Vaccines